Lindsay Zilliox

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Assessing autonomic dysfunction in early diabetic neuropathy

Lindsay Zilliox, Amanda Peltier, Patricia A. Wren et al. · Neurology · 2011 · 152 citations · Full text

Treatment of Diabetic Sensory Polyneuropathy

Lindsay Zilliox, James W. Russell · Current Treatment Options in Neurology · 2011 · 97 citations · Full text

Peripheral Nerve Injury, Diabetes, Diabetic Neuropathy +5

Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance

Lindsay Zilliox, Sandra K. Ruby, Sujal Singh et al. · Journal of Diabetes and its Complications · 2015 · 83 citations · Full text

Metabolic Syndrome, Diabetes Management, Neurophysiology +9

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text